Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Suven Life Sciences Limited (NSE: SUVEN), ISIN INE495B01038 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SUVEN last traded at ₹282.70 (+3.06%), with a 52-week range of ₹124.11 to ₹403.35 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 65.47%, FIIs 0.45%, DIIs 2.17%, mutual funds 0.08%.
EquiSense Score (ECS): 38/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.